(CNN) – The US Food and Drug Administration has approved a new cholesterol-lowering medication.
Esperion’s Nexletol is a once-daily tablet and is an alternative for millions of patients that can’t take or don’t respond well to statins.
The company says it’s the first oral non-statin drug approved in nearly two decades.
During studies, the drug reduced cholesterol in patients by an average of 18 percent when used with moderate or high-intensity statins.
The new drug could become available as early as late March.
- US Census continues 2020 count despite coronavirus outbreak
- NASA call for astronauts draws 12,000 spaceflight hopefuls
- ‘This is bigger than just hockey’: Lightning’s Ryan McDonagh weighs in on coronavirus pandemic
- Truckers say personal cars making job more difficult during coronavirus pandemic
- NFL to begin season as scheduled in September